Validity and reliability of the swedish version of the memorial symptom assessment scale (MSAS)

An instrument for the evaluation of symptom prevalence, characteristics, and distress

Maria Browall, Elisabeth Kenne Sarenmalm, Salmir Nasic, Yvonne Wengström, Fannie Gaston Johansson

Research output: Contribution to journalArticle

Abstract

Context: There are few scales in Swedish that assess symptoms in the dimensions of frequency, severity, and distress. Objectives: The purpose of this study was to translate and determine the validity and reliability of the Memorial Symptom Assessment Scale (MSAS) in a Swedish population of postmenopausal women newly diagnosed with primary or recurrent breast cancer. Methods: The original 32-item MSAS, a self-report measure for assessing symptom distress and frequency in cancer patients, was translated and administered to 206 patients (primary, n = 150 and recurrent, n = 56). Results: The MSAS psychological symptom subscale correlated with the emotional and cognitive functioning subscales of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and showed the highest correlation with the EORTC QLQ-C30 emotional functioning subscale (r = -0.78; P <0.01). The psychological symptom subscale also correlated with the Hospital Anxiety and Depression Scale (HADS) within values for anxiety (r = 0.68; P <0.01) and with the EORTC QLQ-C30 within cognitive functioning values (r = -0.58; P <0.01). The Global Distress Index (GDI)-MSAS showed satisfactory correlations with the EORTC QLQ-C30 emotional functioning subscale (r = -0.75; P <0.01), whereas the correlation between the GDI-MSAS and the EORTC QLQ-C30 cognitive functioning subscale was somewhat lower (r = -0.54; P <0.01). Correlations between the GDI-MSAS and the HADS anxiety subscale were confirmed (r = 0.62; P <0.01), and a correlation between the MSAS physical symptom items and symptom items in the EORTC-QLQ-C30 was evident (r = 0.60-0.85; P <0.01). Cronbach's alpha coefficients for the MSAS and MSAS subscales based on symptom scores ranged from 0.80 to 0.89. The internal consistency at different time points was satisfactory, ranging from 0.86 (baseline) to 0.90 (follow-up). Conclusion: The Swedish version of the MSAS presents as a valid and reliable measure for assessing symptom distress, severity, and frequency in Swedish patients diagnosed with primary and recurrent breast cancer.

Original languageEnglish (US)
Pages (from-to)131-141
Number of pages11
JournalJournal of Pain and Symptom Management
Volume46
Issue number1
DOIs
StatePublished - Jul 2013

Fingerprint

Symptom Assessment
Reproducibility of Results
Anxiety
Depression
Breast Neoplasms
Psychology
Self Report
Neoplasms
Quality of Life
Organizations

Keywords

  • breast cancer
  • Memorial Symptom Assessment Scale
  • MSAS
  • Symptom
  • validation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Nursing(all)

Cite this

Validity and reliability of the swedish version of the memorial symptom assessment scale (MSAS) : An instrument for the evaluation of symptom prevalence, characteristics, and distress. / Browall, Maria; Kenne Sarenmalm, Elisabeth; Nasic, Salmir; Wengström, Yvonne; Gaston Johansson, Fannie.

In: Journal of Pain and Symptom Management, Vol. 46, No. 1, 07.2013, p. 131-141.

Research output: Contribution to journalArticle

@article{b64795a5ab9541c3a5f6ef4e88547038,
title = "Validity and reliability of the swedish version of the memorial symptom assessment scale (MSAS): An instrument for the evaluation of symptom prevalence, characteristics, and distress",
abstract = "Context: There are few scales in Swedish that assess symptoms in the dimensions of frequency, severity, and distress. Objectives: The purpose of this study was to translate and determine the validity and reliability of the Memorial Symptom Assessment Scale (MSAS) in a Swedish population of postmenopausal women newly diagnosed with primary or recurrent breast cancer. Methods: The original 32-item MSAS, a self-report measure for assessing symptom distress and frequency in cancer patients, was translated and administered to 206 patients (primary, n = 150 and recurrent, n = 56). Results: The MSAS psychological symptom subscale correlated with the emotional and cognitive functioning subscales of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and showed the highest correlation with the EORTC QLQ-C30 emotional functioning subscale (r = -0.78; P <0.01). The psychological symptom subscale also correlated with the Hospital Anxiety and Depression Scale (HADS) within values for anxiety (r = 0.68; P <0.01) and with the EORTC QLQ-C30 within cognitive functioning values (r = -0.58; P <0.01). The Global Distress Index (GDI)-MSAS showed satisfactory correlations with the EORTC QLQ-C30 emotional functioning subscale (r = -0.75; P <0.01), whereas the correlation between the GDI-MSAS and the EORTC QLQ-C30 cognitive functioning subscale was somewhat lower (r = -0.54; P <0.01). Correlations between the GDI-MSAS and the HADS anxiety subscale were confirmed (r = 0.62; P <0.01), and a correlation between the MSAS physical symptom items and symptom items in the EORTC-QLQ-C30 was evident (r = 0.60-0.85; P <0.01). Cronbach's alpha coefficients for the MSAS and MSAS subscales based on symptom scores ranged from 0.80 to 0.89. The internal consistency at different time points was satisfactory, ranging from 0.86 (baseline) to 0.90 (follow-up). Conclusion: The Swedish version of the MSAS presents as a valid and reliable measure for assessing symptom distress, severity, and frequency in Swedish patients diagnosed with primary and recurrent breast cancer.",
keywords = "breast cancer, Memorial Symptom Assessment Scale, MSAS, Symptom, validation",
author = "Maria Browall and {Kenne Sarenmalm}, Elisabeth and Salmir Nasic and Yvonne Wengstr{\"o}m and {Gaston Johansson}, Fannie",
year = "2013",
month = "7",
doi = "10.1016/j.jpainsymman.2012.07.023",
language = "English (US)",
volume = "46",
pages = "131--141",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Validity and reliability of the swedish version of the memorial symptom assessment scale (MSAS)

T2 - An instrument for the evaluation of symptom prevalence, characteristics, and distress

AU - Browall, Maria

AU - Kenne Sarenmalm, Elisabeth

AU - Nasic, Salmir

AU - Wengström, Yvonne

AU - Gaston Johansson, Fannie

PY - 2013/7

Y1 - 2013/7

N2 - Context: There are few scales in Swedish that assess symptoms in the dimensions of frequency, severity, and distress. Objectives: The purpose of this study was to translate and determine the validity and reliability of the Memorial Symptom Assessment Scale (MSAS) in a Swedish population of postmenopausal women newly diagnosed with primary or recurrent breast cancer. Methods: The original 32-item MSAS, a self-report measure for assessing symptom distress and frequency in cancer patients, was translated and administered to 206 patients (primary, n = 150 and recurrent, n = 56). Results: The MSAS psychological symptom subscale correlated with the emotional and cognitive functioning subscales of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and showed the highest correlation with the EORTC QLQ-C30 emotional functioning subscale (r = -0.78; P <0.01). The psychological symptom subscale also correlated with the Hospital Anxiety and Depression Scale (HADS) within values for anxiety (r = 0.68; P <0.01) and with the EORTC QLQ-C30 within cognitive functioning values (r = -0.58; P <0.01). The Global Distress Index (GDI)-MSAS showed satisfactory correlations with the EORTC QLQ-C30 emotional functioning subscale (r = -0.75; P <0.01), whereas the correlation between the GDI-MSAS and the EORTC QLQ-C30 cognitive functioning subscale was somewhat lower (r = -0.54; P <0.01). Correlations between the GDI-MSAS and the HADS anxiety subscale were confirmed (r = 0.62; P <0.01), and a correlation between the MSAS physical symptom items and symptom items in the EORTC-QLQ-C30 was evident (r = 0.60-0.85; P <0.01). Cronbach's alpha coefficients for the MSAS and MSAS subscales based on symptom scores ranged from 0.80 to 0.89. The internal consistency at different time points was satisfactory, ranging from 0.86 (baseline) to 0.90 (follow-up). Conclusion: The Swedish version of the MSAS presents as a valid and reliable measure for assessing symptom distress, severity, and frequency in Swedish patients diagnosed with primary and recurrent breast cancer.

AB - Context: There are few scales in Swedish that assess symptoms in the dimensions of frequency, severity, and distress. Objectives: The purpose of this study was to translate and determine the validity and reliability of the Memorial Symptom Assessment Scale (MSAS) in a Swedish population of postmenopausal women newly diagnosed with primary or recurrent breast cancer. Methods: The original 32-item MSAS, a self-report measure for assessing symptom distress and frequency in cancer patients, was translated and administered to 206 patients (primary, n = 150 and recurrent, n = 56). Results: The MSAS psychological symptom subscale correlated with the emotional and cognitive functioning subscales of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and showed the highest correlation with the EORTC QLQ-C30 emotional functioning subscale (r = -0.78; P <0.01). The psychological symptom subscale also correlated with the Hospital Anxiety and Depression Scale (HADS) within values for anxiety (r = 0.68; P <0.01) and with the EORTC QLQ-C30 within cognitive functioning values (r = -0.58; P <0.01). The Global Distress Index (GDI)-MSAS showed satisfactory correlations with the EORTC QLQ-C30 emotional functioning subscale (r = -0.75; P <0.01), whereas the correlation between the GDI-MSAS and the EORTC QLQ-C30 cognitive functioning subscale was somewhat lower (r = -0.54; P <0.01). Correlations between the GDI-MSAS and the HADS anxiety subscale were confirmed (r = 0.62; P <0.01), and a correlation between the MSAS physical symptom items and symptom items in the EORTC-QLQ-C30 was evident (r = 0.60-0.85; P <0.01). Cronbach's alpha coefficients for the MSAS and MSAS subscales based on symptom scores ranged from 0.80 to 0.89. The internal consistency at different time points was satisfactory, ranging from 0.86 (baseline) to 0.90 (follow-up). Conclusion: The Swedish version of the MSAS presents as a valid and reliable measure for assessing symptom distress, severity, and frequency in Swedish patients diagnosed with primary and recurrent breast cancer.

KW - breast cancer

KW - Memorial Symptom Assessment Scale

KW - MSAS

KW - Symptom

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=84880312150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880312150&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2012.07.023

DO - 10.1016/j.jpainsymman.2012.07.023

M3 - Article

VL - 46

SP - 131

EP - 141

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 1

ER -